
Keywords: DMSO; Thal; Thalidomide; VTE; venous thrombosis; Dex; dexamethasone; vWF; von Willebrand factor; ECs; endothelial cells; IL-6; interleukin-6; TNFα; tumor necrosis factor; HUVECs; human umbilical vein endothelial cells; DMSO; dimethyl sulfoxide; FITC; Fluoresce